A canine model of experimental infection with Leishmania (L.) mexicana

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Cruz Chan, Julio Vladimir ^a   Aguilar Cetina, Amarú Del Carmen ^a   Villanueva Lizama, Liliana Estefanía ^a   Martínez Vega, Pedro Pablo ^a   Ramírez Sierra, Maria Jesús ^a   Rosado Vallado, Miguel Enrique ^a   Guillermo Cordero, José Leonardo ^a   Dumonteil, Eric ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b TULANE UNIVERSITY   (United States)

Author keywords

Canine model; Experimental infection; Leishmaniasis

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAGLE; CANINE MODEL; DISEASE ASSOCIATION; EXPERIMENTAL INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; LEISHMANIA MEXICANA INFECTION; LEISHMANIASIS; MALE; NONHUMAN; PARASITE LOAD; SKIN ULCER; SPLENOMEGALY; ANIMAL; DISEASE MODEL; DOG; LEISHMANIA MEXICANA; PARASITOLOGY; PATHOLOGY; SKIN LEISHMANIASIS;

LEISHMANIA MEXICANA;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS;

EID: 84908066132     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-361     Document Type: Article

References (63)

1. Leishmaniasis worldwide and global estimates of its incidence. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, PloS One 2012 7 5 35671
2. Report of the consultative meeting on cutaneous leishmaniasis (WHO/HTM/NTD/IDM/2008.7). WHO, Geneva, Switzerland: WHO 2008 36
3. Control of the leishmaniasis: report of a meeting of the WHO committe on the control of the Leishmaniasis. WHO, WHO Tech Rep Ser 2010 949 xii-xiii 1 186
4. The development and clinical evaluation of second-generation leishmaniasis vaccines. Duthie MS, Raman VS, Piazza FM, Reed SG, Vaccine 2012 30 2 134 141
5. Current knowledge of Leishmania vectors in Mexico: how geographic distributions of species relate to transmission areas. Gonzalez C, Rebollar-Tellez EA, Ibanez-Bernal S, Becker-Fauser I, Martinez-Meyer E, Peterson AT, Sanchez-Cordero V, Am J Trop Med Hyg 2011 85 5 839 846
6. Bridging the innovation gap for neglected tropical diseases in Mexico: capacity building for the development of a new generation of antipoverty vaccines. Bottazzi ME, Dumonteil E, Valenzuela JG, Betancourt-Cravioto M, Tapia-Conyer R, Hotez PJ, Bol Med Hosp Infant Mex 2011 68 2 130 138
7. Vaccines for canine leishmaniasis. Palatnik-de-Sousa CB, Front Immunol 2012 3 69
8. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M, Nat Rev Microbiol 2007 5 11 873 882
9. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Dantas-Torres F, Vet Parasitol 2007 149 3-4 139 146
10. [Canine tegumentar leishmaniasis in the town of Balneario Camboriu in the State of Santa Catarina]. Heusser Junior A, Bellato V, Souza AP, Moura AB, Sartor AA, Santos EG, Silva VL, Rev Soc Bras Med Trop 2010 43 6 713 718
11. Cutaneous and visceral leishmaniasis in dogs from a rural community in northeastern Brazil. Dantas-Torres F, de Paiva-Cavalcanti M, Figueredo LA, Melo MF, da Silva FJ, da Silva AL, Almeida EL, Brandao-Filho SP, Vet Parasitol 2010 170 3-4 313 317
12. A leishmaniosis surveillance system among stray dogs in the region of Madrid: ten years of serodiagnosis (1996-2006). Miro G, Montoya A, Mateo M, Alonso A, Garcia S, Garcia A, Caballero MJ, Molina R, Parasitol Res 2007 101 2 253 257
13. Canine leishmaniasis in southeastern Spain. Martin-Sanchez J, Morales-Yuste M, Acedo-Sanchez C, Baron S, Diaz V, Morillas-Marquez F, Emerg Infect Dis 2009 15 5 795 798
14. Prospective study on the incidence and progression of clinical signs in naive dogs naturally infected by Leishmania infantum. Foglia Manzillo V, Di Muccio T, Cappiello S, Scalone A, Paparcone R, Fiorentino E, Gizzarelli M, Gramiccia M, Gradoni L, Oliva G, PLoS Negl Trop Dis 2013 7 5 2225
15. Seroepidemiology of canine leishmaniosis in Evora (southern Portugal): 20-year trends. Schallig HD, Cardoso L, Semiao-Santos SJ, Parasit Vectors 2013 6 100
16. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two. Miro G, Cardoso L, Pennisi MG, Oliva G, Baneth G, Trends Parasitol 2008 24 8 371 377
17. How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy. Costa CH, Rev Soc Bras Med Trop 2011 44 2 232 242
18. A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies. Aslan H, Dey R, Meneses C, Castrovinci P, Jeronimo SM, Oliva G, Fischer L, Duncan RC, Nakhasi HL, Valenzuela JG, Kamhawi S, J Infect Dis 2013 207 8 1328 1338
19. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Alexander J, Bryson K, Immunol Lett 2005 99 1 17 23
20. Canine leishmaniasis: epidemiological risk and the experimental model. Moreno J, Alvar J, Trends Parasitol 2002 18 9 399 405
21. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part one. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L, Trends Parasitol 2008 24 7 324 330
22. Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs. Manna L, Reale S, Viola E, Vitale F, Manzillo VF, Michele PL, Caracappa S, Gravino AE, Vet Parasitol 2006 142 3-4 271 280
23. Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis. Carrillo E, Ahmed S, Goldsmith-Pestana K, Nieto J, Osorio Y, Travi B, Moreno J, McMahon-Pratt D, Vaccine 2007 25 8 1534 1543
24. Cytokine and phenotypic cell profiles of Leishmania infantum infection in the dog. Maia C, Campino L, J Trop Med 2012 2012 541571
25. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Reis AB, Giunchetti RC, Carrillo E, Martins-Filho OA, Moreno J, Trends Parasitol 2010 26 7 341 349
26. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Poot J, Rogers ME, Bates PA, Vermeulen A, Vet Parasitol 2005 130 1-2 41 53
27. An epidemic outbreak of canine cutaneous leishmaniasis in Colombia caused by Leishmania braziliensis and Leishmania panamensis. Velez ID, Carrillo LM, Lopez L, Rodriguez E, Robledo SM, Am J Trop Med Hyg 2012 86 5 807 811
28. Leishmania (Viannia) infection in the domestic dog in Chaparral, Colombia. Santaella J, Ocampo CB, Saravia NG, Mendez F, Gongora R, Gomez MA, Munstermann LE, Quinnell RJ, Am J Trop Med Hyg 2011 84 5 674 680
29. Canine leishmaniasis in México: the detection of a new focus of canine leishmaniasis in the state of Guerrero correlates with an increase of human cases. Rosete-Ortiz D, Berzunza-Cruz MS, Salaiza-Suazo NL, González C, Treviño-Graza N, Ruiz-Remogio A, Gudiño-Zayas ME, Beltran-Silva S, Romero-Zamora JL, Ugarte-Soto A, Rivas-Sánchez B, Becker I, Bol Med Hosp Infant Mex 2011 68 2 88 93
30. Leishmaniasis cutánea de perros en México. Velasco-Castrejón O, Rivas-Sanchez B, Munguia-Saldaña A, Hobart O, Enf Inf Microbiol 2009 29 3 135 140
31. Clinical and hematological findings in Leishmania braziliensis-infected dogs from Pernambuco, Brazil. Figueredo LA, de Paiva-Cavalcanti M, Almeida EL, Brandao-Filho SP, Dantas-Torres F, Rev Bras Parasitol Vet 2012 21 4 418 420
32. Canine American cutaneous leishmaniasis: a clinical and immunological study in dogs naturally infected with Leishmania braziliensis braziliensis in an endemic area of Rio de Janeiro, Brazil. Pirmez C, Coutinho SG, Marzochi MC, Nunes MP, Grimaldi G Jr, Am J Trop Med Hyg 1988 38 1 52 58
33. Experimental canine mucocutaneous leishmaniasis (Leishmania braziliensis braziliensis). Pirmez C, Marzochi MC, Coutinho SG, Mem Inst Oswaldo Cruz 1988 83 2 145 151
34. An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens. Teixeira MC, Oliveira GG, Santos PO, Bahiense TC, da Silva VM, Rodrigues MS, Larangeira DF, Dos-Santos WL, Pontes-de-Carvalho LC, Mem Inst Oswaldo Cruz 2011 106 2 182 189
35. Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. Weirather JL, Jeronimo SM, Gautam S, Sundar S, Kang M, Kurtz MA, Haque R, Schriefer A, Talhari S, Carvalho EM, Donelson JE, Wilson ME, J Clin Microbiol 2011 49 11 3892 3904
36. Lymphoid organ weights and organ:body weight ratios of growing beagles. Yang TS, Gawlak SL, Lab Anim 1989 23 143 146
37. Immunopathology of natural Trypanosoma cruzi infection in dogs. Cruz-Chan JV, Bolio-González ME, Colin-Flores R, Ramirez-Sierra MJ, Quijano-Hernandez IA, Dumonteil E, Vet Parasitol 2009 162 151 155
38. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis. Aguilar-Be I, da Silva Zardo R, Paraguai de Souza E, Borja-Cabrera GP, Rosado-Vallado M, Mut-Martin M, Garcia-Miss MR, de Sousa CB P, Dumonteil E, Infect Immun 2005 73 2 812 819
39. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, Mayrink W, Guerra LL, Andrade RA, Correa-Oliveira R, Martins-Filho OA, Vet Immunol Immunopathol 2006 112 3-4 102 116
40. Evaluation of TNF-alpha, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs. Michelin AF, Perri SH, De Lima VM, Ann Trop Med Parasitol 2011 105 5 373 383
41. Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis. Costa DJ, Carvalho RM, Abbehusen M, Teixeira C, Pitombo M, Trigo J, Nascimento F, Amorim L, Abreu-Silva AL, do Socorro Pires Cruz M, Miranda JC, Fukutani K, de Oliveira CI, Barral A, Barral-Netto M, Brodskyn C, PloS One 2013 8 4 60535
42. A follow-up of Beagle dogs intradermally infected with Leishmania chagasi in the presence or absence of sand fly saliva. Paranhos-Silva M, Oliveira GG, Reis EA, de Menezes RM, Fernandes O, Sherlock I, Gomes RB, Pontes-de-Carvalho LC, dos-Santos WL, Vet Parasitol 2003 114 2 97 111
43. Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. Alves CF, de Amorim IF, Moura EP, Ribeiro RR, Alves CF, Michalick MS, Kalapothakis E, Bruna-Romero O, Tafuri WL, Teixeira MM, Melo MN, Vet Immunol Immunopathol 2009 128 4 349 358
44. Infectivity of promastigotes and amastigotes of leishmania infantum in a canine model for leishmaniosis [In Process Citation]. Campino L, Santos-Gomes G, Rica Capela MJ, Cortes S, Abranches P, Vet Parasitol 2000 92 4 269 275
45. Chronic hepatitis associated with canine leishmaniosis (Leishmania infantum): a clinicopathological study of 26 cases. Rallis T, Day MJ, Saridomichelakis MN, Adamama-Moraitou KK, Papazoglou L, Fytianou A, Koutinas AF, J Comp Pathol 2005 132 2-3 145 152
46. Pathologic mechanisms underlying the clinical findings in canine leishmaniasis due to Leishmania infantum/chagasi. Koutinas AF, Koutinas CK, Vet Pathol 2014 51 2 527 538
47. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. Aguilar Torrentera F, Lambot MA, Laman JD, Van Meurs M, Kiss R, Noel JC, Carlier Y, Am J Trop Med Hyg 2002 66 3 273 279
48. Visceral leishmaniosis caused by Leishmania (L.) mexicana in a Mexican patient with human immunodeficiency virus infection. Ramos-Santos C, Hernandez-Montes O, Sanchez-Tejeda G, Monroy-Ostria A, Mem Inst Oswaldo Cruz 2000 95 5 733 737
49. Leishmania mexicana mexicana: genetic heterogeneity of mexican isolates revealed by restriction length polymorphism analysis of kinetoplast DNA. Berzunza-Cruz M, Bricaire G, Romero SZ, Perez-Becker R, Saavedra-Lira E, Perez-Montfort R, Crippa-Rossi M, Velasco-Castrejon O, Becker I, Exp Parasitol 2000 95 4 277 284
50. Experimental canine leishmaniasis: clinical, parasitological and serological follow-up. Maia C, Nunes M, Cristovao J, Campino L, Acta Trop 2010 116 3 193 199
51. Canine infection and the possible role of dogs in the transmission of American tegumentary leishmaniosis in Salta, Argentina. Padilla AM, Marco JD, Diosque P, Segura MA, Mora MC, Fernandez MM, Malchiodi EL, Basombrio MA, Vet Parasitol 2002 110 1-2 1 10
52. Vector transmission of leishmania abrogates vaccine-induced protective immunity. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL, PLoS Pathog 2009 5 6 1000484
53. Clinical, parasitologic, and immunologic evolution in dogs experimentally infected with sand fly-derived Leishmania chagasi promastigotes. Travi BL, Osorio EY, Saldarriaga OA, Cadena H, Tabares CJ, Peniche A, Lee S, Melby PC, Am J Trop Med Hyg 2009 81 6 994 1003
54. IgG1 is pathogenic in Leishmania mexicana infection. Chu N, Thomas BN, Patel SR, Buxbaum LU, J Immunol 2010 185 11 6939 6946
55. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Deplazes P, Smith NC, Arnold P, Lutz H, Eckert J, Parasite Immunol 1995 17 9 451 458
56. Immunoglobulin G and E responses in various stages of canine leishmaniosis. Iniesta L, Gallego M, Portus M, Vet Immunol Immunopathol 2005 103 1-2 77 81
57. Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Carvalho MG, Mayrink W, Franca-Silva JC, Giunchetti RC, Genaro O, Correa-Oliveira R, Res Vet Sci 2006 81 1 68 75
58. Leishmanial infection: analysis of its first steps: a review. de Almeida MC, Vilhena V, Barral A, Barral-Netto M, Mem Inst Oswaldo Cruz 2003 98 7 861 870
59. Relationship of Leishmania-specific IgG levels and IgG avidity with parasite density and clinical signs in canine leishmaniasis. Teixeira Neto RG, Giunchetti RC, Carneiro CM, Vitor RW, Coura-Vital W, Quaresma PF, Ker HG, de Melo LA, Gontijo CM, Reis AB, Vet Parasitol 2010 169 3-4 248 257
60. Immunologic indicators of clinical progression during canine Leishmania infantum infection. Boggiatto PM, Ramer-Tait AE, Metz K, Kramer EE, Gibson-Corley K, Mullin K, Hostetter JM, Gallup JM, Jones DE, Petersen CA, Clin Vaccine Immunol: CVI 2010 17 2 267 273
61. Cytokine and transcription factor profiles in the skin of dogs naturally infected by Leishmania (Leishmania) chagasi presenting distinct cutaneous parasite density and clinical status. Menezes-Souza D, Correa-Oliveira R, Guerra-Sa R, Giunchetti RC, Teixeira-Carvalho A, Martins-Filho OA, Oliveira GC, Reis AB, Vet Parasitol 2011 177 1-2 39 49
62. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs. Cardoso L, Schallig HD, Cordeiro-da-Silva A, Cabral M, Alunda JM, Rodrigues M, Vet Immunol Immunopathol 2007 117 1-2 35 41
63. Immunopathology of leishmaniasis: an update. Mansueto P, Vitale G, Di Lorenzo G, Rini GB, Mansueto S, Cillari E, Int J Immunopathol Pharmacol 2007 20 3 435 445